fda warning peptides bpc-157 not approved for human use scientists flag concerns with as RFK bpc-157 not approved for human

The changes are significant enough that other people start commenting

- Ideal for Those with Absorption Issues: Individuals with absorption difficulties due to conditions such as pernicious anemia or gastrointestinal disorders can benefit significantly from B12 injections, as these issues often prevent adequate absorption of oral supplements

Other substituents: modifications can fine-tune potency and selectivity, potentially reducing off-target activity

High-dose methionine (above 100 mg per injection) can elevate homocysteine levels in susceptible individuals, increasing cardiovascular risk if used long-term without folate co-supplementation

Active Ingredient Tirzepatide (Zepbound) Inactive Ingredients Sodium chloride Sodium phosphate dibasic heptahydrate Water for injection Hydrochloric acid solution and/or sodium hydroxide solution may have been added to adjust the pH Contraindications A personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Known serious hypersensitivity to tirzepatide or any of the excipients in Zepbound

The sustained and growing body of research on this compound, spanning multiple countries, research institutions, and animal models, reflects a level of reproducibility that supports continued serious investigation